1 FDA Code of Federal Regulations Title 21, Volume 2. "Qualified health claims: plant sterol / stanol esters and risk for coronary heart disease". Sec. 101.83. April 2002. [FDA]

 

2 Ellegård LH, Andersson SW, Normén AL, Andersson HA. Dietary plant sterols and cholesterol metabolism. Nutr Rev; 2007 Jan;65(1):39-45. [Pubmed]

 

3 Gouni-Berthold I, Berthold HK. Policosanol: Clinical pharmacology and therapeutic

significance of a new lipid-lowering agent. Am Heart J 2002. [Pubmed]

 

4 Frankel EN, Kanner J, German JB et al. Inhibition of oxidation of human low-density

lipoprotein by phenolic substances in red wine. Lancet 1993. [Pubmed]

 

5 Refsum H, Ueland PM, Nygard O, et al . Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49 :31-62. [Pubmed]

 

6 McKully K S, "Homocysteine, folate, vitamin B6 and cardiovascular disease", J. Am. Med.

Assoc. (1998), 279: pp. 392-393. [JAMA]

 

7 Castano G, Mas Ferreiro R, Fernandez L, Gamez R, Illnait J, Fernandez C. A long-term study of policosanol in the treatment of intermittent claudication. Angiology. 2001 Feb;52(2):115-25. [Pubmed]

 

8 Robinson AW, Sloan HL, et al. Use of Niacin in the Prevention and Management of

Hyperlipidemia. Progress in Cardiovascular Nursing 2001; 16(1):14-20. [Pubmed]

 

9 Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int.J Epidemiol 1995;24:704-9. [Oxford Journal]

 

10 Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999;99 (1):178-182. [American Heart Association]

 

11 Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285: 2486-2497. [JAMA]

 

12 Silagy C, Neil A. Garlic as a lipid lowering agent--a meta-analysis. J R Coll Physicians Lond. 1994 Jan-Feb;28(1):39-45. [Pubmed]

 

13 Providencia R. Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. Rev Port Cardiol. 2006 Nov;25(11):1043-58. [Pubmed]

 

14 McCarty MF. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. Med Hypotheses. 2002 Sep;59(3):268-79. Review. [Pubmed]

 

15 FDA. Settlement Reached for Health Claim Relating B Vitamins and Vascular Disease. May 15, 2001. [FDA]

 

16 Alberto Ascherio, Meir J. Stampfer, Walter C. Willett. Trans Fatty Acids and Coronary Heart Disease. Departments of Nutrition and Epidemiology, Harvard School of Public Health. The Channing Laboratory, Department of Medicine, Brigham and Women's Hospital. 1994. [Harvard]